STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News:
The Nomination Committee of Elekta AB (publ) proposes that the 2014 Annual General Meeting reelect Board members Laurent Leksell, Hans Barella, Luciano Cattani, Siaou-Sze Lien, Wolfgang Reim, Jan Secher, Birgitta Stymne Göransson and Tomas Puusepp. It is proposed that Laurent Leksell be reelected as Chairman of the Board. The Nomination Committee’s proposal entails that the number of Board members will continue to be eight.
The Nomination Committee’s other proposals to the Annual General Meeting to be held on August 28, 2014 will be available from the company’s website in conjunction with the publication of the notice of the Annual General Meeting.
The Nomination Committee prior to the 2014 Annual General Meeting comprises the following members:
- Laurent Leksell (Chairman), appointed by the Leksell family for the family’s direct and indirect holdings and in his capacity as Chairman of the Board.
- Åsa Nisell, appointed by Swedbank Robur Funds
- Anders Oscarsson, appointed by AMF and AMF Funds
- Peter Rudman, appointed by Nordea Funds
- Erik Sjöström, appointed by Skandia
- Caroline Leksell Cooke, co-opted member
For further information, please contact: Gert van Santen, Group Vice President Corporate Communications, Elekta AB Tel: +31 653 561 242, e-mail: email@example.com Time zone: CET: Central European Time
Johan Andersson, Director, Investor Relations, Elekta AB Tel: +46 702 100 451, e-mail: firstname.lastname@example.org Time zone: CET: Central European Time
The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 07:30 CET on April 17, 2014.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,500 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker STO:EKTAB. Website: www.elekta.com.
This information was brought to you by Cision http://news.cision.com